Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 42 Records) |
| Query Trace: Atrial Fibrillation and CYP2C9[original query] |
|---|
| Prediction of stable acenocoumarol dose by a pharmacogenetic algorithm. Pharmacogenetics and genomics 2014 Oct 24 (10): 501-13. Jiménez-Varo Enrique, Cañadas-Garre Marisa, Gutiérrez-Pimentel María J, Calleja-Hernández Miguel |
| [Impact of six genetic polymorphisms on Warfarin maintenance dose variation in Chinese Han population]. Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2014 Jun 31 (3): 367-71. Lou Ying, Han Lulu, Li Yan, Zhang Xiaoxing, Liu Zhihong, Tang Min, Yu Haiwen, Wang Wei, Xu Jianping, Liu Hong, Li Yis |
| Pharmacogenetics role in the safety of acenocoumarol therapy. Thrombosis and haemostasis 2014 Sep 112 (3): 522-36. Jiménez-Varo E, Cañadas-Garre M, Henriques C I, Pinheiro A M, Gutiérrez-Pimentel M J, Calleja-Hernández M |
| Lack of Association of Clinical Factors (SAMe-TT2R2) with CYP2C9/VKORC1 Genotype and Anticoagulation Control Quality. Journal of stroke 2015 May 17 (2): 192-8. Park Yun Kyung, Lee Mi Ji, Kim Jae Ha, Kim Suk Jae, Kim June Soo, Lee Soo-Youn, Bang Oh You |
| Factors influencing quality of anticoagulation control and warfarin dosage in patients after aortic valve replacement within the 3 months of follow up. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 2016 Jun 67 (3): 385-93. Wypasek E, Mazur P, Bochenek M, Awsiuk M, Grudzien G, Plincer D, Undas |
| [Establishment and evaluation of a warfarin-dosing algorithm in Chinese Han population]. Zhonghua yi xue za zhi 2016 Mar 96 (10): 776-80. Li C B, Dai D P, Hu G X, Pu C W, Cao Y P, Cai J |
| Warfarin dose requirements with different genotypes of CYP2C9 and VKORC1 for patients with atrial fibrillation and valve replacement. International journal of clinical pharmacology and therapeutics 2017 02 55 (2): 126-132. Chen Weirong, Wu Luhua, Liu Xin, Shen Yue, Liang Yan, Zhu Jun, Tan Huiqiong, Yang Yanmin, Liu Qun, Wang Mingsheng, Liu Lisheng, Wang Xing |
| Clinical application of a new warfarin-dosing regimen based on the CYP2C9 and VKORC1 genotypes in atrial fibrillation patients. Biomedical reports 2016 Apr 4 (4): 453-458. Jiang Nian-Xin, Ge Jun-Wei, Xian Yu-Qiong, Huang Shao-Ying, Li Yan-So |
| [HAS-BLED and HEMORR2HAGES Scales in Assessment of Bleeding Risk in Patients on Long-Term Warfarin Therapy]. Kardiologiia 2015 55 (9): 50-6. Moreva O V, Kropacheva E S, Panchenko E P, Dobrovolsky A B, Zemlyanskaya O A, Donnikov A E, Titaeva E V, Guskova I |
| High prevalence of VKORC1*3 (G9041A) genetic polymorphism in north Indians: A study on patients with cardiac disorders on acenocoumarol. Drug discoveries & therapeutics 2016 9 (6): 404-10. Sehgal Tushar, Hira Jasbir Kaur, Ahluwalia Jasmina, Das Reena, Vijayvergiya Rajesh, Rana Sandip Singh, Varma Neel |
| Genetic and Non-Genetic Factors Affecting the Quality of Anticoagulation Control and Vascular Events in Atrial Fibrillation. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2017 Apr . Park Yun Kyung, Lee Mi Ji, Kim Jae Ha, Lee Jin Soo, Park Rae Woong, Kim Gyeong-Moon, Chung Chin-Sang, Lee Kwang Ho, Kim June Soo, Lee Soo-Youn, Bang Oh You |
| Predictors of warfarin dose requirements in South African patients attending an anticoagulation clinic. Journal of vascular nursing : official publication of the Society for Peripheral Vascular Nursing 2017 Mar 35 (1): 27-30. Schapkaitz Elise, Sithole Johan |
| The rs2108622 polymorphism is related to the early risk of ischemic stroke in non-valvular atrial fibrillation subjects under oral anticoagulation. The pharmacogenomics journal 2017 Dec . Colàs-Campàs L, Royo J L, Montserrat M V, Marzo C, Molina-Seguín J, Benabdelhak I, Cambray S, Purroy |
| Impact of GGCX polymorphisms on warfarin dose requirements in atrial fibrillation patients. Turkish journal of medical sciences 2017 08 47 (4): 1239-1246. Jiang Nian-Xin, Xu Ying-Hui, Xia Jing-Wen, Jiang Bing, Li Yan-So |
| DNA sensors to assess the effect of VKORC1 and CYP2C9 gene polymorphisms on warfarin dose requirement in Chinese patients with atrial fibrillation. Australasian physical & engineering sciences in medicine 2017 Jan . Huang Tao-Sheng, Zhang Ling, He Qiong, Li Yu-Bin, Dai Zhong-Li, Zheng Jian-Rui, Cheng Pei-Qi, He Yun-Sh |
| Clinical and genetic factors influencing acenocoumarol dosing: a cross-sectional study. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2018 6 29 (6): 496-500. Vázquez Carolina, Orlova María, Scibona Paula, Ferreyro Bruno L, Otero Victoria, Jáuregui Esteban G, Arbelbide Jorge, Belloso Waldo |
| Genetic causes of resistance to vitamin K antagonists in Polish patients: a novel p.Ile123Met mutation in VKORC1 gene. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2018 5 29 (5): 429-434. Wzorek Joanna, Wypasek Ewa, Awsiuk Magdalena, Potaczek Daniel P, Undas Anet |
| Pharmacogenetics of vitamin K antagonists and bleeding risk prediction in atrial fibrillation. European journal of clinical investigation 2018 Mar e12929. Serna María José, Rivera-Caravaca José Miguel, Gonzalez-Conejero Rocío, Esteve-Pastor María Asunción, Valdés Mariano, Vicente Vicente, Lip Gregory Y H, Roldán Vanessa, Marín Francis |
| Rationale, design, and preliminary results of the Quebec Warfarin Cohort Study. Clinical cardiology 2018 3 41 (5): 576-585. Perreault Sylvie, Shahabi Payman, Côté Robert, Dumas Stéphanie, Rouleau-Mailloux Étienne, Feroz Zada Yassamin, Provost Sylvie, Mongrain Ian, Dorais Marc, Huynh Thao, Kouz Simon, Diaz Ariel, Blostein Mark, de Denus Simon, Turgeon Jacques, Ginsberg Jeffrey, Lelorier Jacques, Lalonde Lyne, Busque Lambert, Kassis Jeannine, Talajic Mario, Tardif Jean-Claude, Dubé Marie-Pier |
| Pharmacokinetic and pharmacodynamic re-evaluation of a genetic-guided warfarin trial. European journal of clinical pharmacology 2018 2 74 (5): 571-582. Zambon Carlo Federico, Pengo Vittorio, Moz Stefania, Bozzato Dania, Fogar Paola, Padoan Andrea, Plebani Mario, Groppa Francesca, De Rosa Giovanni, Padrini Rober |
| Association between HNF4A mutations and bleeding complications in patients with stable international normalized ratio. Pharmacogenetics and genomics 2019 Oct 29 (8): 200-206. Kim Woorim, Yee Jeong, Chang Byung Chul, Chung Jee Eun, Lee Kyung Eun, Gwak Hye S |
| Polymorphisms of CYP2C9*2, CYP2C9*3 and VKORC1 genes related to time in therapeutic range in patients with atrial fibrillation using warfarin. The application of clinical genetics 2019 12 151-159. da Silveira Maria Mariana Barros Melo, Melo Leiliandry de Araújo, Gomes Filipe Maia Ferreira, Andrade Leonardo José de Cupertino Barreto da Rocha, Serur Isabela Paulino, Piscoya Isabelle Cecília de Vasconcellos, Gueiros Raposo Marina, Palmeira do Ó Kleyton, de Lima Raul Emídio, Brasileiro Victor Arthur Eulálio, Vasconcelos Luydson Richardson Silva, Sobral Filho Dário Celesti |
| Effects of Polymorphisms in Myc-Related Genes on Bleeding Complications in Patients with Stable Warfarin Responses. Cardiovascular therapeutics 2019 2019 1813747. Yee Jeong, Kim Woorim, Chang Byung Chul, Chung Jee Eun, Lee Kyung Eun, Gwak Hye S |
| Effects of rare CYP2C9 alleles on stable warfarin doses in Chinese Han patients with atrial fibrillation. Pharmacogenomics 2020 9 21 (14): 1021-1031. Wang Dongxu, Dai Da-Peng, Wu Hualan, Chong Jia, Lü You, Yin Ruoyun, Zhao Xinlong, Zhao Anxu, Yang Jiefu, Chen H |
| Pharmacogenetic-Guided Algorithm to Improve Daily Dose of Warfarin in Elder Han-Chinese Population. Frontiers in pharmacology 2020 8 11 1014. Ren Yirong, Yang Chenguang, Chen Hao, Dai Dapeng, Wang Yan, Zhu Huolan, Wang Fa |
| Interactive Association Between CYP2C9 rs2860905 Polymorphism and Atrial Fibrillation on Ischemic Stroke in Taiwan Biobank Participants. Pharmacogenomics and personalized medicine 2021 14 1087-1092. Peng Jui-Wen, Nfor Oswald Ndi, Ho Chien-Chang, Hsu Shu-Yi, Lung Chia-Chi, Tantoh Disline Manli, Chou Ming-Chih, Liaw Yung- |
| Incremental Value of Genotype Bins over the HAS-BLED Score for the Prediction of Bleeding Risk in Warfarin-Treated Patients with Atrial Fibrillation. Cardiology research and practice 2021 12 2021 9030005. Liu Jia, Wang Guanyun, Qin Liu'an, Wu Yangxun, Zou Yuting, Wang Xuyun, Wang Ziqian, Wang Yuyan, Zhang Shizhao, Zhang Yuxiao, Yin To |
| Genetic and Nongenetic Determinants of Variable Warfarin Dose Requirements: A Report from North India. Public health genomics 2021 10 1-9. Kaur Navjot, Pandey Avaneesh, Shafiq Nusrat, Gupta Ankur, Das Reena, Singh Harkant, Ahluwalia Jasmina, Malhotra Sam |
| Clinical significance of the series of CYP2C9*non3 variants, an unignorable predictor of warfarin sensitivity in Chinese population. Frontiers in cardiovascular medicine 2022 12 9 1052521. Wang Dongxu, Wu Hualan, Dong Min, Zhang Qing, Zhao Anxu, Zhao Xinlong, Chong Jia, Du Minghui, Wang Yan, Shi Haifeng, Wang Shuanghu, Wang Fang, Cai Jianping, Yang Jiefu, Dai Dapeng, Chen H |
| Optimisation of warfarin-dosing algorithms for Han Chinese patients with CYP2C9*13 variants. European journal of clinical pharmacology 2023 7 . Dongxu Wang, Hualan Wu, Qing Zhang, Xiaoyue Zhou, Yang An, Anxu Zhao, Jia Chong, Shuanghu Wang, Fang Wang, Jiefu Yang, Dapeng Dai, Hao Ch |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 18, 2023
- Content source: